An Open-Label, Fixed Sequence, Single and Multiple Dose Study in Male and Female Subjects to Investigate the Potential for Pharmacokinetic and Pharmacodynamic Interaction Between Metformin and JNJ-28431754
Phase of Trial: Phase I
Latest Information Update: 04 Jul 2016
At a glance
- Drugs Canagliflozin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics; Pharmacokinetics
- 26 Feb 2013 Primary endpoint amended as reported by ClinicalTrials.gov.
- 21 Jan 2013 Study location based on health authority info.
- 21 Jan 2013 New trial record